Altimmune Stock Skyrockets on NAFLD Drug Trial Data

ALT is trading at its highest level since mid-September

Digital Content Manager
Dec 21, 2022 at 2:30 PM
facebook X logo linkedin


Altimmune Inc (NASDAQ:ALT) and SINTX Technologies Inc (NASDAQ:SINT) are trending today. The former announced its experimental drug to treat nonalcoholic fatty liver disease (NAFLD) patients met the main goal of an early-stage trial, and the latter secured a contract from the Missile Defense Agency for electrochemical machining. Below, let's dig deeper into how ALT and SINT are responding to these updates.
 

ALT Looks Ripe for Short Squeeze

Last seen up 15.6% at $13.76, ALT earlier broke through long-term resistance at its 80-day moving average to trade at its highest level since mid-September. The shares are building off yesterday's roughly 16% gain, and are adding to a healthy 47.8% year-to-date lead.

A short squeeze could fuel additional tailwinds. Though short sellers are already hitting the exits, with short interest down 10% during the most recent reporting period, the 6.56 million shares sold short still make up a hefty 13.4% of Altimmune stock's available float.

 

Technical Resistance Pressures SINT

SINT is surging as well, up 79.4% at $13.40 at last check. The security is bouncing off yesterday's record low of $6.46, though its 60-day moving average and the $15 level are capping today's gains. Over the past 1-2 months, SINTX Technologies stock is down 83.7%.

There are only two brokerages covering the security, but they are both bullish with a "buy" rating. Plus, the stock's 12-month consensus target price of $117.50 is a 849.1%  premium to current levels.

 

Target Effortless Triple-Digit Gains Every Sunday Evening For Life!

This is your chance to triple your profit potential on Sunday evenings, without spending all your free time watching the market.

On Sundays, as a Weekend Plus subscriber, you’ll get up to 6 trades every Sunday, each targeting gains of 200% or more.

Start targeting gains like the ones our subscribers have seen recently, including:

213.3% GAIN on AutoNation calls
100.0% GAIN on Monster Beverage calls
100.4% GAIN on Walgreens Boots Alliance puts
100.4% GAIN on ON Semiconductor calls
257.7% GAIN on Dell calls

101.0% GAIN on Apollo Global Management calls
103.6% GAIN on JP Morgan  Chase calls
105.3% GAIN on DraftKings calls
101.3% GAIN on Airbnb calls
203.0% GAIN on Shopify calls
102.0% GAIN on Cboe Global Markets calls
100.9% GAIN on Boeing calls
102.1% GAIN on Microsoft puts
102.3% GAIN on First Solar calls
101.5% GAIN on PulteGroup calls
101.0% GAIN on Apple calls
209.4% GAIN on NXP Semiconductors calls
100.8% GAIN on Uber Technologies calls
100.4% GAIN on Academy Sports and Outdoors puts
102.2% GAIN on Trade Desk calls
100.8% GAIN on DoorDash calls
100.0% GAIN on Camping World Holdings puts
100.0% GAIN on Cboe Global Markets calls
100.2% GAIN on C3.ai calls
238.5% GAIN on Oracle calls

 
 
 


 
 

Rainmaker Ads CGI